These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8403466)

  • 21. Therapy with fluconazole for tinea corporis, tinea cruris, and tinea pedis.
    Montero-Gei F; Perera A
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S77-81. PubMed ID: 1562699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tinea corporis/cruris: new treatment options.
    van Heerden JS; Vismer HF
    Dermatology; 1997; 194 Suppl 1():14-8. PubMed ID: 9154395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus.
    Tausch I; Decroix J; Gwiezdzinski Z; Urbanowski S; Baran E; Ziarkiewicz M; Levy G; Del Palacio A
    Int J Dermatol; 1998 Feb; 37(2):140-2. PubMed ID: 9542675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ; Wiseman LR; Markham A
    Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Itraconazole in the treatment of tinea corporis: a pilot study.
    Nuijten ST; Schuller JL
    Rev Infect Dis; 1987; 9 Suppl 1():S119-20. PubMed ID: 3027835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative evaluation of fluconazole 50 mg and 100 mg versus itraconazole 100 mg in the treatment of dermatomycoses].
    Lospalluti M; Barile F; Pantaleo AK; Conese M; Guerra AP; Lo Re M; D'Amico G; Barbieri G
    Clin Ter; 1994 Feb; 144(2):129-38. PubMed ID: 8181207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, randomized, stratified controlled study of the treatment of tinea imbricata with oral terbinafine or itraconazole.
    Budimulja U; Kuswadji K; Bramono S; Basuki J; Judanarso LS; Untung S; Widagdo S; Rohprabowo ; Wydianto ; Koesanto D
    Br J Dermatol; 1994 Apr; 130 Suppl 43():29-31. PubMed ID: 8186139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial.
    Singal A; Pandhi D; Agrawal S; Das S
    J Dermatolog Treat; 2005; 16(5-6):331-5. PubMed ID: 16428155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of short-duration oral terbinafine for the treatment of tinea corporis or tinea cruris in subjects with HIV infection or diabetes.
    Rich P; Houpt KR; LaMarca A; Loven KH; Marbury TC; Matheson R; Miller B; Smith S; Wolf J;
    Cutis; 2001 Jul; 68(1 Suppl):15-22. PubMed ID: 11499330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Itraconazole in the treatment of tinea capitis.
    Degreef H
    Cutis; 1996 Jul; 58(1):90-3. PubMed ID: 8823558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral treatment of tinea corporis and tinea cruris with terbinafine and griseofulvin: a randomized double blind comparative study.
    Voravutinon V
    J Med Assoc Thai; 1993 Jul; 76(7):388-93. PubMed ID: 8089640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative double-blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea cruris.
    del Palacio Hernandez A; López Gómez S; González Lastra F; Moreno Palancar P; Iglesias Díez L
    Clin Exp Dermatol; 1990 May; 15(3):210-6. PubMed ID: 2194715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris.
    Lebwohl M; Elewski B; Eisen D; Savin RC
    Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A short-term treatment of tinea corporis and tinea cruris with oral terbinafine].
    Shiraki Y; Hiruma M; Inoue A; Matsushita A; Ogawa H
    Nihon Ishinkin Gakkai Zasshi; 2003; 44(2):121-5. PubMed ID: 12748594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
    Bonifaz A; Saúl A
    Eur J Dermatol; 2000 Mar; 10(2):107-9. PubMed ID: 10694308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of tinea capitis with itraconazole capsule pulse therapy.
    Gupta AK; Hofstader SL; Summerbell RC; Solomon R; Adam P; Alexis M; Raboobee N; De Doncker P
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 1):216-9. PubMed ID: 9704832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris-A prospective trial.
    Khurana A; Agarwal A; Singh A; Sardana K; Ghadlinge M; Agrawal D; Panesar S; Sethia K; Chowdhary A
    Mycoses; 2021 Dec; 64(12):1480-1488. PubMed ID: 34532888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole.
    Möhrenschlager M; Schnopp C; Fesq H; Strom K; Beham A; Mempel M; Thomsen S; Brockow K; Wessner DB; Heidelberger A; Ruhdorfer S; Weigl L; Seidl HP; Ring J; Abeck D
    Br J Dermatol; 2000 Nov; 143(5):1011-5. PubMed ID: 11069511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of tinea capitis caused by Microsporum ferrugineum with itraconazole.
    Wisuthsarewong W; Chaiprasert A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S72-9. PubMed ID: 16856430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single dose (400 mg) versus 7 day (200 mg) daily dose itraconazole in the treatment of tinea versicolor: a randomized clinical trial.
    Wahab MA; Ali ME; Rahman MH; Chowdhury SA; Monamie NS; Sultana N; Khondoker L
    Mymensingh Med J; 2010 Jan; 19(1):72-6. PubMed ID: 20046175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.